Results 111 to 120 of about 4,813,424 (302)

Tooth Extraction Timing After Head and Neck Radiotherapy: A Critical Reappraisal of Osteoradionecrosis Risk and Biological Vulnerability

open access: yesMethods and Protocols
Aims: To critically reappraise the post-radiotherapy tooth-extraction waiting-period paradigm and examine whether extraction timing is better interpreted within a broader framework of biological vulnerability than as an isolated temporal determinant of ...
Erkan Topkan   +3 more
doaj   +1 more source

Intrapatient tumour heterogeneity and clonal evolution in an autopsy study of metastatic salivary gland cancer

open access: yesMolecular Oncology, EarlyView.
Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche   +10 more
wiley   +1 more source

Illegal racial discrimination in jury selection: A continuing legacy

open access: yes, 2010
Nearly 135 years after Congress passed the Civil Rights Act of 1875 to eliminate racial discrimination in jury selection, people of color continue to be excluded from jury service because of their race, especially in serious criminal trials and death ...

core  

Selection bias [PDF]

open access: yesCanadian Medical Association Journal, 2017
openaire   +2 more sources

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

open access: yesMolecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi   +6 more
wiley   +1 more source

Selection Bias in College Admissions Test Scores [PDF]

open access: yes
Data from college admissions tests can provide a valuable measure of student achievement, but the non-representativeness of test-takers is an important concern. We examine selectivity bias in both state-level and school-level SAT and ACT averages.
Jesse Rothstein   +2 more
core  

Mitigating Selection Bias in Recommendation Systems Through Sentiment Analysis and Dynamic Debiasing

open access: yesApplied Sciences
Selection bias can cause recommendation systems to over-rely on users’ historical behavior and ignore potential interests, thus reducing the diversity and accuracy of recommendations.
Fan Zhang, Wenjie Luo, Xiudan Yang
doaj   +1 more source

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

open access: yesMolecular Oncology, EarlyView.
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira   +7 more
wiley   +1 more source

Selection bias in epidemiologic studies

open access: yes, 2017
Bias is inherent in epidemiology, and researchers go to great lengths to avoid introducing bias into their studies. However, some bias is inevitable, and bias due to selection is particularly common.
Mark S. Gilthorpe (8081840)   +2 more
core   +3 more sources

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

open access: yesMolecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy